GSK (NYSE:GSK) shares rose for seven straight periods, because the inventory was up 1.4% greater at $40.62 on Monday.
The pharmaceutical large gained over 6.5% within the previous six periods. The inventory has climbed over 20% thus far this yr, whereas within the yr 2024, GSK
